Programmed cell death 10 can be used as a potential biomarker for ankylosing spondylitis diagnosis and treatment

Ebrahimiadib N, Berijani S, Ghahari M, Pahlaviani FG. Ankylosing spondylitis. J Ophthalmic Vis Res. 2021;16:462–9.

PubMed  PubMed Central  Google Scholar 

Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369:1379–90.

Article  PubMed  Google Scholar 

Sparks JA, Costenbader KH. Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases. Rheum Dis Clin North Am. 2014;40:637–57.

Article  PubMed  PubMed Central  Google Scholar 

Wang XB, Ellis JJ, Pennisi DJ, Song X, Batra J, Hollis K, et al. Transcriptome analysis of ankylosing spondylitis patients before and after TNF-alpha inhibitor therapy reveals the pathways affected. Genes Immun. 2017;18:184–90.

Article  PubMed  CAS  Google Scholar 

Poddubnyy D, Sieper J. Diagnostic delay in axial spondyloarthritis - a past or current problem? Curr Opin Rheumatol. 2021;33:307–12.

Article  PubMed  Google Scholar 

Sieper J, Poddubnyy D. New evidence on the management of spondyloarthritis. Nat Rev Rheumatol. 2016;12:282–95.

Article  PubMed  CAS  Google Scholar 

Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet. 2005;76:42–51.

Article  PubMed  CAS  Google Scholar 

Valentino M, Dejana E, Malinverno M. The multifaceted PDCD10/CCM3 gene. Genes Dis. 2021;8:798–813.

Article  PubMed  CAS  Google Scholar 

Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, et al. Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. Ann Rheum Dis. 2019;78:1536–44.

Article  PubMed  Google Scholar 

Wordsworth BP, Cohen CJ, Davidson C, Vecellio M. Perspectives on the genetic associations of ankylosing spondylitis. Front Immunol. 2021;12:603726.

Chen B, Li J, He C, Li D, Tong W, Zou Y, et al. Role of HLA-B27 in the pathogenesis of ankylosing spondylitis. Mol Med Rep. 2017;15:1943–51.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pimentel-Santos FM, Mourão AF, Ribeiro C, Costa J, Santos H, Barcelos A, et al. Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, BASMI and mSASSS reference centile charts. Clin Rheumatol. 2012;31:447–54.

Article  PubMed  Google Scholar 

Khanna M, Keightley A. MRI of the axial skeleton manifestations of ankylosing spondylitis. Clin Radiol. 2005;60:135–6.

Article  PubMed  CAS  Google Scholar 

Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2010;52:1000–8.

Article  Google Scholar 

Creemers MC, Franssen MJ, van’t Hof MA, Gribnau FW, van de Putte LB, van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005;64:127–9.

Article  PubMed  CAS  Google Scholar 

Wang Y, Liu H, Zhang Y, Ma D. cDNA cloning and expression of an apoptosis-related gene, humanTFAR15 gene. Sci China C Life Sci. 1999;42:323–9.

Article  PubMed  CAS  Google Scholar 

Stahl S, Gaetzner S, Voss K, Brackertz B, Schleider E, Sürücü O, et al. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex. Hum Mutat. 2008;29:709–17.

Article  PubMed  CAS  Google Scholar 

Cigoli MS, Avemaria F, De Benedetti S, Gesu GP, Accorsi LG, Parmigiani S, et al. PDCD10 gene mutations in multiple cerebral cavernous malformations. PLoS ONE. 2014;9:e110438.

Article  PubMed  PubMed Central  Google Scholar 

Huang DN, Zhao HS. PDCD10,a novel signal transduction regulating molecule with multiple functions. Chin J Biochem Mol Biol. 2013;24:306–10.

Google Scholar 

Ma X, Zhao H, Shan J, Long F, Chen Y, Chen Y, et al. PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol Biol Cell. 2007;18:1965–78.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang H, Ma X, Deng X, Chen Y, Mo X, Zhang Y, et al. PDCD10 interacts with STK25 to accelerate cell apoptosis under oxidative stress. Front Biosci. 2012;17:2295–305.

Article  Google Scholar 

Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N. Pathogenesis of ankylosing spondylitis - recent advances and future directions. Nat Rev Rheumatol. 2017;13:359–67.

Article  PubMed  CAS  Google Scholar 

Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis–insights into pathogenesis. Nat Rev Rheumatol. 2016;12:81–91.

Article  PubMed  CAS  Google Scholar 

Danve A, O’Dell J. The ongoing quest for biomarkers in ankylosing spondylitis. Int J Rheum Dis. 2015;18:826–34.

Article  PubMed  CAS  Google Scholar 

Corr M. Wnt signaling in ankylosing spondylitis. Clin Rheumatol. 2014;33:759–62.

Article  PubMed  Google Scholar 

Yang PT, Xiao WG, Qin L, Zhao LJ, He LM, Ito M. A pilot study on changes of macrophage colony stimulating factor and transforming growth factor beta1 in male patients with ankylosing spondylitis taking thalidomide. Ann Rheum Dis. 2010;69:781–2.

Article  PubMed  CAS  Google Scholar 

Zhang H, Lin M, Dong C, Tang Y, An L, Ju J, et al. An MST4-pbeta-Catenin(Thr40) signaling axis controls intestinal stem cell and tumorigenesis. Adv Sci. 2021;8:e2004850.

Article  Google Scholar 

Thompson BJ, Sahai E. MST kinases in development and disease. J Cell Biol. 2015;210:871–82.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Comments (0)

No login
gif